+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent Advances in Copper Intercalators as Anticancer Agents



Recent Advances in Copper Intercalators as Anticancer Agents



Journal of Fluorescence 28(5): 1195-1205



Copper is a part of various enzymes and helps them to function properly. It can be effectively used to produce promising anticancer drugs and presently, many studies are being pursued worldwide on the development of copper-based complexes as potential anticancer drugs. Herein, we briefly discuss the importance of reactive oxygen species in biological applications and copper(II) complexes as anticancer drugs. The anti-angiogenic properties of mono-nuclear copper(II) complexes have been demonstrated by in vivo chick embryo angiogenesis analysis. The plausible mechanism behind anticancer activity of these complexes is by the formation of excessive intracellular Reactive Oxygen Species (ROS). ROS is a composite term used for oxygen derivative non-radicals and free radicals of highly reactive components, that enhances the killing response of immune cells to microbial invasion. Previous reports have shown that ROS plays an important role as a messenger in cell cycling and normal cell signal transduction. Graphical Abstract The generation of singlet oxygen and healing the tumor cells with singlet oxygen in presence of UV-light.

(PDF emailed within 0-6 h: $19.90)

Accession: 065898743

Download citation: RISBibTeXText

PMID: 30171479

DOI: 10.1007/s10895-018-2283-7


Related references

Transition Metal Intercalators as Anticancer Agents-Recent Advances. International Journal of Molecular Sciences 17(11), 2016

Advances in copper complexes as anticancer agents. Chemical Reviews 114(1): 815-862, 2014

Recent advances in the new generation taxane anticancer agents. Medicinal Chemistry ) 1(2): 125-139, 2006

Overview: Recent Advances in Antifolates as Anticancer Agents. Expert Opinion on Therapeutic Patents 2(12): 1979-1992, 1992

Recent Advances in Development of Polyphenols as Anticancer Agents. Mini Reviews in Medicinal Chemistry 18(15): 1265-1269, 2018

Novel anticancer agents and targets: recent advances and future perspectives. Mini Reviews in Medicinal Chemistry 13(9): 1239-1255, 2014

Recent Advances of Natural and Synthetic β-Carbolines as Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 15(5): 537-547, 2016

Recent Advances in the Development of Indazole-based Anticancer Agents. Chemmedchem 13(15): 1490-1507, 2018

Recent advances in oral anticancer agents for colon cancer. Future Oncology 9(12): 1893-1908, 2014

Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents. Current Drug Targets 13(11): 1432-1444, 2013

Recent advances in pharmacologic study of natural anticancer agents in China. Memorias do Instituto Oswaldo Cruz 86 Suppl 2: 51-54, 1991

Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents. European Journal of Medicinal Chemistry 142: 459-485, 2017

Recent advances in multinuclear complexes as potential anticancer and DNA binding agents. Anti-Cancer Agents in Medicinal Chemistry 14(1): 147-169, 2014

Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents. Current Medicinal Chemistry 20(5): 694-709, 2014

Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments. Science Progress 97(Pt 1): 20-40, 2014